Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AME✓SelectedUSD · AMEGSK vs AME performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs AME

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.3%
AME return
+68.8%
Excess return
-28.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioAMEExcessAlpha
1D-1.6%-1.9%+0.3%-1.3%
7D-4.7%-4.1%-0.6%-4.1%
30D-4.7%-6.6%+1.9%-3.9%
3M-8.8%-4.8%-3.9%-8.4%
6M-4.6%+4.8%-9.4%-6.5%
YTD+1.0%+13.1%-12.1%-2.6%
1Y+6.9%+21.4%-14.5%+1.6%
3Y+52.5%+51.4%+1.2%+35.4%
5Y+40.3%+67.6%-27.3%+14.7%
All+40.3%+68.8%-28.5%+14.7%

Cumulative growth

Daily Returns

Daily percentage return beside AME.

Daily Out/Under-Performance

Portfolio return minus AME return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded AME wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling